Order Article Reprints

Jagomäe T, Seppa K, Reimets R, Pastak M, Plaas M, Hickey MA, Kukker KG, Moons L, De Groef L, Vasar E, et al. Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype. Cells. 2021; 10(11):3193. https://doi.org/10.3390/cells10113193

Jagomäe, Toomas, Kadri Seppa, Riin Reimets, Marko Pastak, Mihkel Plaas, Miriam A. Hickey, Kaia Grete Kukker, Lieve Moons, Lies De Groef, Eero Vasar, and et al. 2021. "Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype" Cells 10, no. 11: 3193. https://doi.org/10.3390/cells10113193

Jagomäe, T., Seppa, K., Reimets, R., Pastak, M., Plaas, M., Hickey, M. A., Kukker, K. G., Moons, L., De Groef, L., Vasar, E., Kaasik, A., Terasmaa, A., & Plaas, M. (2021). Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype. Cells, 10(11), 3193. https://doi.org/10.3390/cells10113193